Discover why the S&P 500 faces a major correction, key risk signs to watch, and when investors may find better entry points.

PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...

A stock market correction is likely in the coming weeks, says Fairlead Strategies' Katie Stockton. Technical indicators suggest a decline of nearly 10% for the S&P 500. Investors should use relief ...